Update on ECMO for COVID-19: What have we learned? Early experience of pump-controlled retrograde trial off for weaning from (VA ECMO) in adult patients with cardiogenic shock
What we have learned about the health-care delivery industry through the COVID-19 pandemic. The goal is to offer provocative opinions, based on real world data, on what we did
Covid-19 - Current challenges for perfusion. Passive antibody therapy. how plasma transfusions from coronavirus survivors may help those in need. Passive antibody therapy